Related StoriesResearchers effectively repair nerve cell harm in Alzheimer's dementiaResearchers identify new focus on for novel immune-oncology treatmentsRice scientists solve long-position mystery about hemophilia proteinUnder the terms of the agreement, Roche provides Aileron guaranteed funding of at least $25 million in technology access charges and R&D support. Aileron is eligible to receive up to $1.1 billion in obligations upon the accomplishment of discovery, advancement, regulatory and commercialisation milestones, if medication candidates are developed against all five targets. In addition, Aileron shall receive royalties on future sales for any marketed items that result from the collaboration.Related StoriesScalable creation of gene therapy vectors: an interview with Frank UbagsUnlocking the genes behind antibiotic resistance: an interview with Professor RomesbergLinkam phases used in the Wolfson Bioimaging Facility at the University of Bristol within the endocytic sorting research of Dr Paul Verkade Coping with priapism is definitely hard enough, but knowing that it can ultimately lead to fibrosis within the male organ adds insult to injury, said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal.